Apimeds Pharmaceuticals US, Inc.

Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.

APUS | NYSE

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 100 MATAWAN RD, 7747 MATAWAN
Website:: https://www.apimedsus.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Apimeds Pharmaceuticals US, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies to treat inflammation and pain. The company's lead program is Apitox, a novel, non-narcotic therapy derived from purified honey bee venom. Apitox is being clinically studied for treating pain and inflammation, particularly in patients with osteoarthritis. Apimeds operates on a principle it calls 'Actual Intelligence (ai²™),' which emphasizes human experience, scientific rigor, and clinical judgment to identify and develop overlooked or distressed clinical assets. This approach guides the company in navigating regulatory, intellectual property, and market access challenges, with a primary commitment to patients and physicians.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Apimeds Pharmaceuticals US, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Apimeds Pharmaceuticals US, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Apimeds Pharmaceuticals US, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Corline Biomedical AB Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.	Sweden	CLBIO
CorMedix Inc. Develops a catheter lock solution to prevent bloodstream infections in hemodialysis patients.	United States of America	CRMD
Cosma Spolka Akcyjna Produces natural hemp supplements and pharmaceutical raw materials for retail & wholesale markets.	Poland	COS
COSMO Pharmaceuticals N.V. Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.	Netherlands	COPN
Cosmos Health Inc. A global healthcare firm developing & distributing nutraceuticals, generics, and OTC medications.	United States of America	COSM
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Biotech firm developing cell therapies for regenerative medicine and immunotherapy applications.	United States of America	CELZ
CRESCENT BIOPHARMA, INC. A biotech company developing bispecific antibody therapies to treat solid tumors.	United States of America	CBIO
Crinetics Pharmaceuticals, Inc. Develops novel therapeutics for rare endocrine diseases and related tumors.	United States of America	CRNX
CRISPR Therapeutics AG Develops transformative CRISPR gene-based medicines for diseases like sickle cell.	United States of America	CRSP
Crossject Develops needle-free auto-injectors for rapid drug delivery in medical emergencies.	France	ALCJ